Vantage Investment Advisors’s Sanofi SNY Stock Holding History

Vantage Investment Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-313	Closed	-$13K	–	805
2018 Q2	$13K	Hold	313	–	–	﹤0.01%	494
2018 Q1	$13K	Hold	313	–	–	﹤0.01%	515
2017 Q4	$13K	Sell	313 -256	-45%	-$11.8K	﹤0.01%	532
2017 Q3	$28K	Hold	569	–	–	0.01%	376
2017 Q2	$12K	Buy	569 +313	+122%	+$15K	﹤0.01%	518
2017 Q1	$12K	Hold	256	–	–	﹤0.01%	500
2016 Q4	$10K	Hold	256	–	–	﹤0.01%	524
2016 Q3	$10K	Buy	+256	New	+$10.3K	﹤0.01%	501
2016 Q1	–	Sell	-550	Closed	-$23K	–	840
2015 Q4	$23K	Buy	+550	New	+$25.3K	0.01%	359
2015 Q3	–	Sell	-1	Closed	–	–	808
2015 Q2	$0	Buy	+1	New	+$51	﹤0.01%	796
2015 Q1	–	Sell	-200	Closed	-$9K	–	871
2014 Q4	$9K	Hold	200	–	–	0.01%	523
2014 Q3	$11K	Hold	200	–	–	0.01%	467
2014 Q2	$11K	Buy	+200	New	+$10.6K	0.01%	463

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Vantage Investment Advisors's SNY Position: Q3 2018 in Review

Vantage Investment Advisors sold out of Sanofi (SNY) in Q3 2018, closing a stake of 313 shares — an estimated $13K sold.

Vantage Investment Advisors first reported a position in SNY in Q2 2014 and held it in 13 quarters. The position peaked at $28K in Q3 2017. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

Vantage Investment Advisors reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
Vantage Investment Advisors sold 313 Sanofi shares in Q3 2018, an estimated $13K.
Vantage Investment Advisors first reported a position in Sanofi in Q2 2014 and held it in 13 quarters.
Vantage Investment Advisors's Sanofi position peaked at $28K in Q3 2017.
480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.